Publication:
Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry

Loading...
Thumbnail Image
Date
2014-03-16
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Gabaldó Barrios, Xavier ; Alonso-Romero, José Luis ; Marín Vera, Miguel ; Marín Zafra, Gema ; Sánchez Henarejos, Pilar ; Sánchez Bermúdez, Ana Isabel ; Ruiz Espejo, Francisco ; Sarabia Meseguer, María Desamparados
item.page.secondaryauthor
item.page.director
Publisher
Springer
publication.page.editor
publication.page.department
DOI
https://doi.org/10.1007/s10689-014-9708-5
item.page.type
info:eu-repo/semantics/article
Description
© Springer Science+Business Media Dordrecht 2014. This document is the Published version of a Published Work that appeared in final form in Familial Cancer. To access the final edited and published work see https://doi.org/10.1007/s10689-014-9708-5
Abstract
Mutations in breast cancer susceptibility (BRCA) genes lead to defects in DNA repair processes resulting in elevated genome instability and predisposing to breast and ovarian cancer. We report a novel mutation (c.1918C>T) in the exon 11 of the BRCA1 gene that consists of a nonsense mutation that causes a stop codon downstream in the 640 position of the protein. The mutation was present in two Spanish unrelated families and was associated with four breast cancer cases, including two bilateral breast cancer (one of them synchronous). The median age/mean age (range) was 48.5/44.25 years (27–53). This finding led us to perform haplotype analysis in all family carriers. Four highly polymorphic microsatellite markers were used (17-3858, 17-3930, D17S855, D17S1326) to establish whether or not all these families had a common ancestor. This analysis showed that all mutation carriers of these families had a common haplotype. None of the noncarriers of the mutation or of the 24 healthy controls showed this haplotype. Therefore, the c.1918C>T mutation carriers from these two families allows us to assert that all analyzed mutation carriers share a common ancestry.
Citation
Familial Cancer (2014) 13:431–435
item.page.embargo
Collections